
Opinion|Videos|May 29, 2024
Dawn of the Age of Adopting PDTs
Paul Jeffrey, PharmD, examines different contracting strategies that can help improve patient access to prescription digital therapeutics (PDTs).
Advertisement
Episodes in this series

Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
CAR T-Cell Therapies, Bispecific Antibodies Usher in New Era in R/R MCL
2
Emerging Breakthroughs in Neurodegenerative Disease Treatments: Kavita Nair, PhD, FAAN
3
Ibrutinib-Based Frontline Regimens Narrow the Survival Gap in CLL
4
Missed Hepatitis B Treatment Opportunities in the US Increase Health Risks
5














































